Illinois increases transparency of prescription drugs in Medicaid

July 15, 2019

Last week, Gov. J.B. Pritzker signed the Medicaid Drug and Therapeutics Board Transparency Bill (HB 2259). HB 2259 seeks to increase transparency in the decision-making process and makeup of the Medicaid Drug and Therapeutics (D&T) Board.

The D&T Board along with the Department of Healthcare and Family Services (HFS) determines the fee-for-service medication formulary in Illinois' Medicaid program.
This law is an important step to increase Medicaid’s transparency and accountability when determining which life-saving medications to provide to Medicaid recipients. 

Medicaid is the #1 insurer for millions of people living with chronic illness like HIV, mental health and other diseases. The ability to access life-saving drugs is essential for people living with chronic illness. 

The bill was sponsored by Rep. Sara Feigenholtz (D-Chicago) in the House and Sen. Julie Morrison (D-Deerfield) in the Senate. AFC is grateful to Gov. Pritzker, Rep. Feigenholtz, and Sen. Morrison for their leadership on this issue.

Categorized under Advocacy.

Recommended Articles